Niemann-Pick type C (NPC) diseases, caused by mutations in NPC1 or NPC2, are rare inherited disorders affecting cholesterol metabolism, and are characterised by progressive neurodegeneration and premature death. In some affected individuals, haematological defects such as thrombocytopenia (low platelet counts) and anaemia are also observed. Louwette et al. now characterise platelet abnormalities in three unrelated patients carrying NPC1 mutations, and in NPC1-depleted zebrafish embryos. In patients, platelets were present in normal numbers but showed functional impairments. Patients’ haematopoietic stem cells were defective in differentiation into megakaryocytes (platelet precursors), although red blood cells differentiated normally. Zebrafish embryos depleted for NPC1 showed abnormal numbers of thrombocytes and red blood cells, suggesting that the entire myeloid lineage was affected. How defects in lipid metabolism caused by NPC1 mutations lead to defects specifically in the myeloid lineage remains an open question.
Niemann-Pick disease and platelet dysfunction
Niemann-Pick disease and platelet dysfunction. Dis Model Mech 1 November 2012; 5 (6): 708. doi:
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists